• Email Preferences
    • Logout
    loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
    • Email Preferences
    • Logout
    loading
    Member
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 107
  3. 108
  4. 109
  5. 110
  6. 111
  7. …
  • Moderna expects interim results from vaccine trial in November

    21 October, 2020

    Moderna’s CEO said that he expects interim results from its coronavirus vaccine trial in...

    COVID-19

  • China has vaccinated 60,000 people with no adverse reactions

    China // 21 October, 2020

    Media reports that China has vaccinated 60,000 people against the coronavirus...

    COVID-19

  • AstraZeneca phase 3 trial in the US may resume this week

    United States // 21 October, 2020

    Media sources reports that AstraZeneca’s Phase 3 COVID-19 vaccine trial...

    COVID-19

  • WHO COVID-19 Weekly Reports, October

    20 October, 2020

    Weekly updates on the global COVID-19 situation...

    COVID-19, General Articles

  • Comparing cloth masks to medical masks in healthcare workers: study

    20 October, 2020

    Different efficacies of cloth masks and medical masks...

    COVID-19

  • Study: survival of SARS-CoV-2 on skin

    20 October, 2020

    A study published in Clinical Infectious Diseases evaluated how long the SARS-CoV-2 virus and influenza A virus survived on skin surfaces.

    COVID-19

  • Masks will still be needed after vaccine is released

    20 October, 2020

    Vaccines will not be a total solution...

    COVID-19

  • Vaccines don't save lives, vaccinations do

    20 October, 2020

    A Discussion Of “Vaccine Hesitancy”...

    COVID-19

  • Unicef to stockpile over half a billion syringes by 2020 end

    20 October, 2020

    UNICEF will stockpile 520 million syringes...

    COVID-19

  • ECDC guidance on COVID-19 infection prevention and control for primary healthcare

    19 October, 2020

    Recommendations for general practitioner practices, dental clinics and pharmacies...

    COVID-19

  • Studies: Quality of life and late effects of COVID-19 survivors

    19 October, 2020

    In a study published in Science Direct, Health -Related Quality of Life (HRQoL) was evaluated in survivors of severe COVID-19 infection at 3 months. A second study (currently a preprint) compared 58 COVID-19 patients, post-hospital discharge, with 30 matched controls (with similar comorbidities) . Similar results were discovered in another preprint study looking at long-term neurologic outcomes, also referred as the “Long-Haul COVID” 3 moths after COVID-19

    COVID-19

  • CEPI selects PT Bio Farma as a manufacturer for a COVID-19 vaccine

    Indonesia // 19 October, 2020

    Media reports that a pharmaceutical company has been selected...

    COVID-19

  • Widespread COVID vaccine could be ready by April, Fauci says

    19 October, 2020

    A “safe and effective” coronavirus vaccine may be widely available by...

    COVID-19

  • India, South Africa ask WTO to ease IP rules for COVID-19

    India // South Africa // 19 October, 2020

    Media reports that South Africa and India have asked the World Trade Organisation (WTO) to...

    COVID-19

  • US to use CVS and Walgreens to vaccinate long-term care residents

    United States // 19 October, 2020

    Media reports that the US administration will contract with CVS and Walgreens...

    COVID-19

  • NHS (UK) in discussions with BMA regarding December vaccine programme

    United Kingdom // 19 October, 2020

    An online magazine for GPs in the UK, reports talks at the...

    COVID-19

  • Long-Term Effects of COVID-19 may Improve with Time

    Austria // 19 October, 2020

    Preliminary evidence finds long term damage from COVID-19 improves over time…

    COVID-19, General Articles

  • Pfizer May Seek EUA by End of November

    United States // 16 October, 2020

    Efficacy and safety data may be ready by end of October…

    COVID-19

  • ECDC guidance on discharging and ending isolation of COVID-19 infected individuals

    16 October, 2020

    Criteria to consider before discharging a COVID-19 patient and when to end isolation...

    COVID-19

  • Apollo hospitals preparing to give one million COVID-19 vaccines a day

    India // 16 October, 2020

    Healthcare provider in India to administer large doses of vaccine...

    COVID-19

  1. …
  2. 107
  3. 108
  4. 109
  5. 110
  6. 111
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS